10
Running head: SCENARIO PATIENT QUESTIONS
References
Cappola, A. R., Arnold, A. M., Wulczyn, K., Carlson, M., Robbins, J., & Psaty, B. M. (2015).
Thyroid function in the euthyroid range and adverse outcomes in older adults. The Journal of
Clinical Endocrinology & Metabolism, 100(3), 1088-1096.
Mammen, J. S., McGready, J., Oxman, R., Chia, C. W., Ladenson, P. W., & Simonsick, E. M.
(2015). Thyroid hormone therapy and risk of thyrotoxicosis in community-resident older adults:
findings from the Baltimore Longitudinal Study of Aging. Thyroid, 25(9), 979-986.
Marvin, K., & Parham, K. (2015). Differentiated thyroid cancer in people aged 85 and older. J
Am Geriatr Soc, 63(5), 932-7.
Stott, D. J., Rodondi, N., Kearney, P. M., Ford, I., Westendorp, R. G., Mooijaart, S. P., ... &
Baumgartner, C. (2017). Thyroid hormone therapy for older adults with subclinical
hypothyroidism. New England Journal of Medicine, 376(26), 2534-2544.
Riedel, T., Rodriguez-Emmenegger, C., de los Santos Pereira, A., Bědajánková, A., Jinoch, P.,
Boltovets, P. M., &Brynda, E. (2014). Diagnosis of Epstein–Barr virus infection in clinical
serum samples by an SPR biosensor assay. Biosensors and Bioelectronics, 55, 278-284.
Azizi, F., Mehran, L., Hosseinpanah, F., Delshad, H., &Amouzegar, A. (2018). Secondary and
tertiary preventions of thyroid disease. Endocrine research, 1-17.